Cahaba Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-561
| Closed | -$279K | – | 159 |
|
|
2025
Q1 | $279K | Buy |
561
+5
| +0.9% | +$2.49K | 0.02% | 120 |
|
|
2024
Q4 | $289K | Sell |
556
-4
| -0.7% | -$2.08K | 0.02% | 120 |
|
|
2024
Q3 | $346K | Buy |
560
+2
| +0.4% | +$1.24K | 0.03% | 110 |
|
|
2024
Q2 | $309K | Sell |
558
-25
| -4% | -$13.8K | 0.03% | 113 |
|
|
2024
Q1 | $339K | Buy |
583
+2
| +0.3% | +$1.16K | 0.03% | 106 |
|
|
2023
Q4 | $308K | Sell |
581
-75
| -11% | -$39.8K | 0.03% | 103 |
|
|
2023
Q3 | $332K | Sell |
656
-8
| -1% | -$4.05K | 0.04% | 100 |
|
|
2023
Q2 | $346K | Sell |
664
-97
| -13% | -$50.6K | 0.04% | 102 |
|
|
2023
Q1 | $439K | Sell |
761
-48
| -6% | -$27.7K | 0.05% | 87 |
|
|
2022
Q4 | $446K | Hold |
809
| – | – | 0.06% | 84 |
|
|
2022
Q3 | $410K | Sell |
809
-55
| -6% | -$27.9K | 0.06% | 83 |
|
|
2022
Q2 | $469K | Sell |
864
-127
| -13% | -$68.9K | 0.07% | 79 |
|
|
2022
Q1 | $547K | Sell |
991
-25
| -2% | -$13.8K | 0.08% | 73 |
|
|
2021
Q4 | $678K | Sell |
1,016
-14
| -1% | -$9.34K | 0.09% | 64 |
|
|
2021
Q3 | $588K | Buy |
+1,030
| New | +$588K | 0.09% | 70 |
|